Towa Pharmaceutical Co., Ltd. (TWAPF)
OTCMKTS · Delayed Price · Currency is USD
25.33
+8.50 (50.51%)
At close: Jun 3, 2025

Towa Pharmaceutical Company Description

Towa Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sale ethical drugs in Japan.

It operates through two segments; Domestic and Overseas. The company provides its products in the therapeutic areas of digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products, as well as provide formulations from Tablets, Capsules, Injectable, Patches, eye drops, and other products.

It also offers IT service related to healthcare; disease risk testing services; and quasi drugs. In addition, the company is involved in research and development and production of active pharmaceutical ingredients, intermediates, support business; and planning, development and OEM manufacturing of health foods, pharmaceuticals, general foods, and other miscellaneous merchandizes.

The company was founded in 1951 and is headquartered in Osaka, Japan.

Towa Pharmaceutical Co., Ltd.
CountryJapan
Founded1951
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees4,788
CEOItsuro Yoshida

Contact Details

Address:
2-11, Shinbashi-cho
Osaka, 571-8580
Japan
Phone81 6 6900 9100
Websitetowayakuhin.co.jp

Stock Details

Ticker SymbolTWAPF
ExchangeOTCMKTS
Stock TypeCommon Stock
Fiscal YearApril - March
Reporting CurrencyJPY
ISIN NumberJP3623150004
SIC Code2834

Key Executives

NamePosition
Itsuro YoshidaPresident and Representative Director
Shiro HatagamiExecutive Officer and GM of Accounting and Finance Division
Norikazu InoueExecutive Officer and GM of Administration Division
Shigeki FujitaOperating Officer and GM of Human Resource Development Center
Yutaka OkudaSenior Exe. Officer and Div Manager of Research & Development Div and Unit Manager of Innovative Tech Research Unit
Masao TanakaDirector
Osamu UchikawaExecutive MD and Director
Tetsuro TabataSenior Executive Officer and GM of Production Division
Takeshi SugiuraExecutive Officer
Yasuyuki OishiExecutive Officer